Login  |  Register

FDA Okays Hetlioz (Tasimelteon) for Sleep Disorder in Blind

Vanda Pharmaceuticals announces FDA approval for its treatment for non-24-hour sleep-wake disorder, a circadian rhythm condition that affects many totally blind patients.

Alexa Traffic